Views & Analysis

Oncology
cancer treatment

Elements in precision oncology

Validating the regulatory expectations on evidential requirements for predictive biomarkers is not a trivial process, but quite conceptually challenging.

Oncology
CAR-TCR 2023 – Josh Ludwig

CAR-TCR 2023 – Josh Ludwig

Innovation was the watchword at CAR-TCR in Boston last month, but one of the limitations of innovation is that it can be challenging for an industry to transition from the rapid iteration s

Oncology
CAR-TCR 2023 – Becky Cap

CAR-TCR 2023 – Becky Cap

In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder